As a potential immunomodulator against TB, allicin can also enhance the activation of the MAPK and SAPK/JNK pathways of Mtb-infected mouse peritoneal macrophages to produce various effectors, such as IL-1β and IL-12. Here, IL1B is linked to tuberculosis.